You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

11C-PiB

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

11C-PIB PET Study in MESA at Columbia University

Enrolling by invitation
  • Cognitive Impairment
  • +3 more
  • 11C-PIB
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2022

[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

Recruiting
  • Alzheimer's Disease
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023

Biodistribution of [11C]PIB in Risk Factors for Alzheimer's

Enrolling by invitation
  • Alzheimer Disease
  • Mild Cognitive Impairment
    • Winston-Salem, North Carolina
      Wake Forest Baptist Medical Center
    Apr 29, 2022

    Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive

    Enrolling by invitation
    • Alzheimer Disease
    • Healthy Aging
    • 11C-PiB
    • Aurora, Colorado
      University of Colorado, Denver
    Jan 12, 2022

    Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)

    Not yet recruiting
    • Alzheimer Disease
    • [11C]-UCB-J
    • +3 more
    • Lille, France
    • +2 more
    Jun 12, 2023

    Depression and Driving

    Recruiting
    • Depression
    • Drive
    • F 18 AV-1451 (Flortaucipir)
    • [11C]-Pittsburgh Compound B ([11C]PiB)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 5, 2022

    Neuroimaging in Healthy Aging and Senile Dementia (HASD IND)

    Recruiting
    • Alzheimer Disease
    • [11C]-Pittsburgh Compound B ([11C]PiB)
    • F 18 AV-1451 (Flortaucipir)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 5, 2022

    Parkinson Disease Trial in Nashville ([11C]-PIB)

    Recruiting
    • Parkinson Disease
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Apr 28, 2022

    Long-term Effects of COVID-19

    Recruiting
    • COVID-19
    • SAR-CoV-2
    • (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)
    • 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)
    • Jacksonville, Florida
      Mayo Clinic Florida
    May 31, 2022

    Ovarian Cancer Trial in Birmingham ([11C]PiB and 18F-labeled DPA-714 PET scan)

    Not yet recruiting
    • Ovarian Cancer
    • [11C]PiB and 18F-labeled DPA-714 PET scan
    • Birmingham, Alabama
      The University of Alabama at Birmingham
    Jun 9, 2022

    Alzheimer Trial in New York (18F-MK-6240, 11C-PIB)

    Enrolling by invitation
    • Alzheimer Disease
    • New York, New York
    • +1 more
    Jul 8, 2021

    Cervical Spondylosis With Myelopathy, Degenerative Cervical Myelopathy Trial in Cambridge (3T MR Imaging of the cervical spinal

    Recruiting
    • Cervical Spondylosis With Myelopathy
    • Degenerative Cervical Myelopathy
    • 3T MR Imaging of the cervical spinal cord
    • +3 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospital
    May 26, 2022

    Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß

    Recruiting
    • Alzheimer Disease
    • 18F-Flortaucipir radiopharmaceutical
    • +2 more
    • Berkeley, California
    • +7 more
    Jan 23, 2023

    NFL LONG Prospective Study

    Enrolling by invitation
    • Concussion, Brain
    • [11C] PiB
    • +2 more
    • Waltham, Massachusetts
    • +2 more
    Sep 28, 2021

    BEAM: Brain-Eye Amyloid Memory Study

    Recruiting
    • Alzheimer's Disease
    • +4 more
    • Pittsburgh Compound B [11C]-PIB
    • Toronto, Ontario, Canada
    • +4 more
    Oct 24, 2022

    Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia Trial in Rochester (Pittsburgh Compound B (C-11 PiB),

    Enrolling by invitation
    • Alzheimer's Disease
    • +3 more
    • Pittsburgh Compound B (C-11 PiB)
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 30, 2022

    Imaging Biomarkers in Preclinical and Symptomatic AD

    Recruiting
    • Alzheimer Disease
    • [11C] Pittsburgh Compound-B (PIB)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 29, 2021

    Neurodegenerative and Related Disorders

    Enrolling by invitation
    • PSP
    • +9 more
    • C-11 PiB
    • AV1451 Tau
    • Rochester, Minnesota
      Mayo Clinic
    Apr 7, 2022

    Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

    Active, not recruiting
    • Tauopathies
    • 11C-HY-2-15 PET
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Sep 6, 2023

    Parkinson's Disease, Multiple System Atrophy, Dementia With Lewy Bodies Trial (C11-SY08)

    Not yet recruiting
    • Parkinson's Disease
    • +3 more
    • (no location specified)
    Oct 24, 2023

    Inflammation in Alzheimer's Disease and Related Dementias Using

    Recruiting
    • Alzheimer Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 9, 2023

    Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

    Recruiting
    • Alzheimer Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 7, 2023

    Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)

    Completed
    • Ketoses, Metabolic
    • Observational heart and kidney on siemens TEP scan
    • Sherbrooke, Quebec, Canada
      Research Center on Aging
    Jan 16, 2023

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

    Not yet recruiting
    • Muscarinic Receptor Occupancy
    • New Haven, Connecticut
      Yale University
    Aug 31, 2023